Table 3.
Univariate Analysis |
Multivariate Analysis |
|||
---|---|---|---|---|
Factor | HR (95% CI) | P Value | HR (95% CI) | P Value |
SAPS II scorea | 1.01 (.99–1.02) | .09 | ||
SOFA scorea | 1.05 (1.01–1.09) | .03 | 1.04 (1.00–1.08) | .05 |
Immunosuppressionb | 1.14 (.81–1.62) | .46 | ||
Reason for ECMO | .38 | |||
Miscellaneousc | 1 | |||
Myocarditis | 0.84 (.49–1.44) | |||
Post–cardiac surgery | 1.20 (.84–1.71) | |||
Location of ECMO cannulation | .09 | .07 | ||
Mobile unit | 1 | 1 | ||
Operating room | 1.10 (.70–1.74) | 1.16 (.71–1.89) | ||
ICU | 0.59 (.35–1.01) | 0.64 (.37–1.10) | ||
Site of ECMO cannulation | .85 | |||
Intrathoracic only | 1 | |||
Extrathoracic only | 0.90 (.60–1.36) | |||
Extrathoracic then intrathoracic | 0.99 (.65–1.51) | |||
Antibiotics at the time of ECMOd | 1.07 (.76–1.51) | .68 | 0.73 (.50–1.05) | .09 |
Abbreviations: CI, confidence interval; ECMO, extracorporeal membrane oxygenation; HR, hazard ratio; ICU, intensive care unit; SAPS II, simplified acute physiology score; SOFA, sequential organ-failure assessment.
a Scores calculated at ICU admission. SAPS II and SOFA scores are correlated (r = 0.57; P < .0001)
b Includes patients with AIDS, solid organ transplantation, or hematological malignancy and those receiving chemotherapy, immunosuppressive agents, or long-term corticosteroid therapy.
c Includes dilated cardiomyopathy, acute myocardial infarction, cardiac arrest, and other medical indications.
d Includes patients who received prophylactic antibiotic therapy for central ECMO placement and those treated with antibiotics for an infection at the time of ECMO cannulation.